ClinVar Miner

Submissions for variant NC_000014.9:g.(?_87934712)_(87950768_?)del

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000535669 SCV000627120 pathogenic Galactosylceramide beta-galactosidase deficiency 2019-12-17 criteria provided, single submitter clinical testing This variant is a gross deletion of the genomic region encompassing exons 11-17 of the GALC gene. While it is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation. Loss-of-function variants in GALC are known to be pathogenic. This particular variant is consistent with the well known 30kb deletion, which is the most common cause of Krabbe disease in the European population, found in more than 30% of affected individuals investigated and at a frequency of 0.2% in a sample of 2,330 control European individuals (PMID: 7581365, 22073273, 26795590). This variant has been associated with an increased risk for primary open-angle glaucoma, but the clinical relevance of this finding is unclear (PMID: 22073273). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.